{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-009793","form_type":"8-K","ticker":null,"cik":"0001402479","company_name":"MedAvail Holdings, Inc.","filed_at":"2024-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.069803+00:00","generated_at":"2026-06-06T09:50:54.986854+00:00","sec_items":["1.03","4.01","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"MedAvail files Chapter 7 bankruptcy; board, execs, auditor resign","bullets":["Filed voluntary Chapter 7 petition on Feb 2, 2024; assets to be liquidated by court-appointed trustee.","SingerLewak LLP resigned as independent auditor effective immediately prior to filing; no audit report had been issued.","All board members (Doerr, Faulkner, Johnson, Kramer, McGraw, Stettin) resigned effective Feb 2.","CEO Mark Doerr and CFO Ramona Seabaugh terminated effective Feb 2 due to bankruptcy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-009793","json":"https://secwatch.observer/filing/0001104659-24-009793.json","markdown":"https://secwatch.observer/filing/0001104659-24-009793.md","text":"https://secwatch.observer/filing/0001104659-24-009793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/tm244766d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T09:50:54.986854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32591ff99dbc2b4a641e5638e8c60add89afce7d","claim":"SingerLewak LLP resigned as auditor of MedAvail Holdings, Inc..","evidence_excerpt":"On February 1, 2024, SingerLewak LLP, the Company’s independent registered public accounting firm, informed the Company of its decision to resign as auditors of the Company, effective immediately prior to the filing of the Petition. From the date of its engagement on June 14, 2023 through the date of its resignation, SingerLewak did not render an audit report on the Company’s financial statements for any period.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"SingerLewak LLP"}],"fact_type":"auditor_change"},{"claim_id":"48dff66c7f5ccb98e5be361a097118bb9669a2d6","claim":"MedAvail Holdings, Inc. entered chapter 7 in United States Bankruptcy Court for the District of Delaware (petition 2024-02-02).","evidence_excerpt":"MedAvail Holdings, Inc., a Delaware corporation (the “ Company ”), filed a voluntary petition for relief (the “ Petition ”) under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “ Code ”) in the United States Bankruptcy Court for the District of Delaware (the “ Bankruptcy Court ”) on February 2, 2024.","evidence_source":"SEC 8-K Item 1.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.9,"family_label":"Distress & Bankruptcy","details":[{"label":"Proceeding","value":"chapter 7"},{"label":"Court","value":"United States Bankruptcy Court for the District of Delaware"},{"label":"Petition","value":"2024-02-02"}],"fact_type":"distress_event"},{"claim_id":"2d1bd62de0","claim":"Laurie McGraw resigned as Director at MedAvail Holdings, Inc..","evidence_excerpt":"Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5456a74057","claim":"Glen Stettin resigned as Director at MedAvail Holdings, Inc..","evidence_excerpt":"Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6acdc02f4d","claim":"Mark Doerr was terminated as President and Chief Executive Officer at MedAvail Holdings, Inc..","evidence_excerpt":"The Company terminated the employment of Mark Doerr, the Company’s President and Chief Executive Officer, and Ramona Seabaugh, the Company’s Chief Financial Officer, Treasurer and Secretary, effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a08284b628","claim":"Paul Johnson resigned as Director at MedAvail Holdings, Inc..","evidence_excerpt":"Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b8dfeae8df","claim":"Mark Doerr resigned as Director at MedAvail Holdings, Inc..","evidence_excerpt":"Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bd57a445f0","claim":"Robert Faulkner resigned as Director at MedAvail Holdings, Inc..","evidence_excerpt":"Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d8a778428e","claim":"Michael Kramer resigned as Director at MedAvail Holdings, Inc..","evidence_excerpt":"Mark Doerr, Robert Faulkner, Paul Johnson, Michael Kramer, Laurie McGraw and Glen Stettin, M.D. tendered their resignations as members of the Company’s Board of Directors, which resignations were effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"e3f89a9546","claim":"Ramona Seabaugh was terminated as Chief Financial Officer, Treasurer and Secretary at MedAvail Holdings, Inc..","evidence_excerpt":"The Company terminated the employment of Mark Doerr, the Company’s President and Chief Executive Officer, and Ramona Seabaugh, the Company’s Chief Financial Officer, Treasurer and Secretary, effective on February 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000110465924009793/0001104659-24-009793-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Financial Officer, Treasurer and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}